{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:23:23Z","timestamp":1793813003095,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-016826"],"award-info":[{"award-number":["INV-016826"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82041021"],"award-info":[{"award-number":["82041021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The global pandemic of coronavirus disease 2019 (COVID-19) has attracted great public health efforts across the world. Few studies, however, have described the potential impact of these measures on other important infectious diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The incidence of 19 major infectious diseases in Zhejiang Province was collected from the National Notifiable Infectious Disease Surveillance System from January 2017 to October 2020. The entire epidemic control phase was divided into three stages. The government deployed the first level response from 24 January to 2 March (the most rigorous measures). When the outbreak of COVID-19 was under control, the response level changed to the second level from 3 to 23 March, and then the third level response was implemented after 24 March. We compared the epidemiological characteristics of 19 major infectious diseases during different periods of the COVID-19 epidemic and previous years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1,814,881 cases of 19 infectious diseases were reported in Zhejiang from January 2017 to October 2020, resulting in an incidence rate of 8088.30 cases per 1,000,000 person-years. After the non-pharmaceutical intervention, the incidence of 19 infectious diseases dropped by 70.84%, from 9436.32 cases per 1,000,000 person-years to 2751.51 cases per 1,000,000 person-years, with the large decrease in the first response period of influenza. However, we observed that the daily incidence of severe fever with thrombocytopenia syndrome (SFTS) and leptospirosis increased slightly (from 1.11 cases per 1,000,000 person-years to 1.82 cases per 1,000,000 person-years for SFTS and 0.30 cases per 1,000,000 person-years to 1.24 cases per 1,000,000 person-years for leptospirosis). There was no significant difference in the distribution of epidemiological characteristic of most infectious diseases before and during the implementation of COVID-19 control measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study summarizes the epidemiological characteristics of 19 infectious diseases and indicates that the rigorous control measures for COVID-19 are also effective for majority of infectious diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07301-w","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:03:42Z","timestamp":1648476222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of 19 major infectious diseases during COVID-19 epidemic and previous years in Zhejiang, implications for prevention measures"],"prefix":"10.1186","volume":"22","author":[{"given":"Haopeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"issue":"6227","key":"7301_CR1","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1126\/science.aaa4339","volume":"347","author":"H Heesterbeek","year":"2015","unstructured":"Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science (New York, NY). 2015;347(6227):4339.","journal-title":"Science (New York, NY)."},{"issue":"7181","key":"7301_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nature06536","volume":"451","author":"KE Jones","year":"2008","unstructured":"Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990\u20133.","journal-title":"Nature"},{"issue":"16","key":"7301_CR3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/cid\/ciaa422","volume":"71","author":"K Liu","year":"2020","unstructured":"Liu K, Ai S, Song S, Zhu G, Tian F, Li H, et al. Population movement, city closure in Wuhan and geographical expansion of the 2019-nCoV pneumonia infection in China in January 2020. Clin Infect Dis. 2020;71(16):2045\u201351.","journal-title":"Clin Infect Dis"},{"issue":"7825","key":"7301_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-020-2293-x","volume":"585","author":"S Lai","year":"2020","unstructured":"Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;585(7825):410\u20133.","journal-title":"Nature"},{"issue":"8","key":"7301_CR5","doi-asserted-by":"publisher","first-page":"e1003244","DOI":"10.1371\/journal.pmed.1003244","volume":"17","author":"MJ Siedner","year":"2020","unstructured":"Siedner MJ, Harling G, Reynolds Z, Gilbert RF, Haneuse S, Venkataramani AS, et al. Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study. PLoS Med. 2020;17(8):e1003244.","journal-title":"PLoS Med"},{"key":"7301_CR6","first-page":"1","volume":"10","author":"H Holt","year":"2021","unstructured":"Holt H, Talaei M, Greenig M, Zenner D, Symons J, Relton C, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 2021;10:1\u201313.","journal-title":"Thorax"},{"issue":"3","key":"7301_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/cid\/ciaa1289","volume":"73","author":"Q Liu","year":"2020","unstructured":"Liu Q, Lu P, Shen Y, Li C, Wang J, Zhu L, et al. Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China. Clin Infect Dis. 2020;73(3):542\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7301_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/iid3.352","volume":"8","author":"D Wu","year":"2020","unstructured":"Wu D, Liu Q, Wu T, Wang D, Lu J. The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China. Immunity Inflam Dis. 2020;8(4):844\u20136.","journal-title":"Immunity Inflam Dis"},{"issue":"37","key":"7301_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.15585\/mmwr.mm6937a6","volume":"69","author":"SJ Olsen","year":"2020","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"7301_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/tropicalmed5030123","volume":"5","author":"KA Alene","year":"2020","unstructured":"Alene KA, Wangdi K, Clements ACA. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview. Trop Med Infect Dis. 2020;5(3):123.","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"7301_CR11","doi-asserted-by":"publisher","first-page":"e83822","DOI":"10.1371\/journal.pone.0083822","volume":"8","author":"M Tian","year":"2013","unstructured":"Tian M, Feng D, Chen X, Chen Y, Sun X, Xiang Y, et al. China\u2019s rural public health system performance: a cross-sectional study. PLoS ONE. 2013;8(12):e83822.","journal-title":"PLoS ONE"},{"issue":"9649","key":"7301_CR12","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/S0140-6736(08)61365-3","volume":"372","author":"L Wang","year":"2008","unstructured":"Wang L, Wang Y, Jin S, Wu Z, Chin DP, Koplan JP, et al. Emergence and control of infectious diseases in China. Lancet. 2008;372(9649):1598\u2013605.","journal-title":"Lancet"},{"key":"7301_CR13","unstructured":"Announcement of the National Health Commission of the People's Republic of China [in Chinese]. 2020. http:\/\/www.nhc.gov.cn\/jkj\/s7916\/202001\/44a3b8245e8049d2837a4f27529cd386.shtml."},{"key":"7301_CR14","unstructured":"Province HCoZ. Provincial COVID-19 epidemic prevention and control work video conference [in Chinese]. 2020. https:\/\/wsjkw.zj.gov.cn\/art\/2020\/1\/23\/art_1663145_47496667.html."},{"key":"7301_CR15","unstructured":"Province TPsGoZ. Press Conference of Zhejiang Covid-19 Epidemic Prevention and Control Work (Session 31) [in Chinese]. 2020. http:\/\/www.zj.gov.cn\/art\/2020\/3\/2\/art_1229000412_802.html."},{"key":"7301_CR16","unstructured":"Province TPsGoZ. Press Conference of Zhejiang Covid-19 Epidemic Prevention and Control Work (Session 38) [in Chinese]. 2020. http:\/\/www.zj.gov.cn\/art\/2020\/3\/23\/art_1229002582_816.html."},{"issue":"3","key":"7301_CR17","first-page":"239","volume":"54","author":"W Chen","year":"2020","unstructured":"Chen W, Wang Q, Peng Z, Zhang R, Chen Q, Feng L, et al. Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(3):239\u201344.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"7301_CR18","unstructured":"China TSCotPsRo. The announcement from Wuhan\u2019s headquarter on the novel coronavirus prevention and control [in Chinese] 2020. http:\/\/www.gov.cn\/xinwen\/2020-01\/23\/content_5471751.htm."},{"key":"7301_CR19","unstructured":"Annoucement on extending 2020 Spring Festival holiday, postponing the resumption of business and the reopening of schools [in Chinese]. 2020. http:\/\/www.ts.gov.cn\/art\/2020\/1\/30\/art_1345186_41862659.html."},{"key":"7301_CR20","unstructured":"The reopening time of school time in Zhejiang province [in Chinese]. 2020. http:\/\/www.zj.gov.cn\/art\/2020\/4\/3\/art_1654331_43627611.html."},{"key":"7301_CR21","unstructured":"Press conference on COVID-19 epidemic prevention and control work in Zhejiang (session 40) [in Chinese]. 2020. http:\/\/www.zj.gov.cn\/art\/2020\/3\/30\/art_1229003169_820.html."},{"issue":"10","key":"7301_CR22","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3201\/eid2610.203193","volume":"26","author":"HH Lee","year":"2020","unstructured":"Lee HH, Lin SH. Effects of COVID-19 Prevention Measures on Other Common Infections. Taiwan Emerg Infect Dis. 2020;26(10):2509\u201311.","journal-title":"Taiwan Emerg Infect Dis"},{"issue":"4","key":"7301_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/tropicalmed5040160","volume":"5","author":"H Mahdi","year":"2020","unstructured":"Mahdi H, Alqahtani A, Barasheed O, Alemam A, Alhakami M, Gadah I, et al. Hand Hygiene knowledge and practices among domestic hajj pilgrims: implications for future mass gatherings amidst COVID-19. Trop Med Infect Dis. 2020;5(4):160.","journal-title":"Trop Med Infect Dis"},{"key":"7301_CR24","doi-asserted-by":"publisher","first-page":"126893","DOI":"10.1016\/j.cej.2020.126893","volume":"405","author":"SV Mohan","year":"2021","unstructured":"Mohan SV, Hemalatha M, Kopperi H, Ranjith I, Kumar AK. SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges. Chem Eng J. 2021;405:126893.","journal-title":"Chem Eng J"},{"issue":"11","key":"7301_CR25","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3201\/eid2611.200861","volume":"26","author":"NS Wong","year":"2020","unstructured":"Wong NS, Leung CC, Lee SS. Abrupt Subsidence of Seasonal Influenza after COVID-19 Outbreak, Hong Kong. China Emerg Infect Dis. 2020;26(11):2753\u20135.","journal-title":"China Emerg Infect Dis"},{"issue":"6","key":"7301_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5582\/ddt.2020.03083","volume":"14","author":"M Bhatt","year":"2020","unstructured":"Bhatt M, Soneja M, Gupta N. Approach to acute febrile illness during the COVID-19 pandemic. Drug discover Therap. 2020;14(6):282\u20136.","journal-title":"Drug discover Therap"},{"key":"7301_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41182-020-00219-6","volume":"48","author":"F Amimo","year":"2020","unstructured":"Amimo F, Lambert B, Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Trop Med Health. 2020;48:32.","journal-title":"Trop Med Health"},{"issue":"1","key":"7301_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12916-020-01710-x","volume":"18","author":"SJ Rogerson","year":"2020","unstructured":"Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18(1):239.","journal-title":"BMC Med"},{"issue":"1","key":"7301_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1473-3099(20)30700-3","volume":"21","author":"DJ Weiss","year":"2021","unstructured":"Weiss DJ, Bertozzi-Villa A, Rumisha SF, Amratia P, Arambepola R, Battle KE, et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2021;21(1):59\u201369.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7301_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40249-020-00788-y","volume":"10","author":"B Shi","year":"2021","unstructured":"Shi B, Zheng J, Xia S, Lin S, Wang X, Liu Y, et al. Accessing the syndemic of COVID-19 and malaria intervention in Africa. Infect Dis Poverty. 2021;10(1):5.","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"7301_CR31","doi-asserted-by":"publisher","first-page":"e1003666","DOI":"10.1371\/journal.pmed.1003666","volume":"18","author":"SC Inzaule","year":"2021","unstructured":"Inzaule SC, Ondoa P, Loembe MM, Tebeje YK, Ouma AEO, Nkengasong JN. COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control. PLoS Med. 2021;18(6):e1003666.","journal-title":"PLoS Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07301-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:04:10Z","timestamp":1648476250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07301-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7301"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07301-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"25 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations. This study was approved by the Ethics Review Committee of School of Public Health, Sun Yat-Sen University (No.: 2020016). Since no personal identifiable information was used in this analysis, the need for informed personal consent was waived by the Ethics Review Committee of School of Public Health, Sun Yat-Sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}